Friday, December 05, 2025 | 01:53 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 2 - Obesity And Health

Eli Lilly expects to launch obesity drug in India next year, says CEO

Mounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both conditions

Eli Lilly expects to launch obesity drug in India next year, says CEO
Updated On : 29 Feb 2024 | 8:13 PM IST

Incisionless device could revolutionise treatment for metabolic diseases

A completely incisionless device that replicates metabolic surgery without making any cuts could surpass current technologies for managing conditions such as severe obesity and type 2 diabetes, a team led by an Indian researcher has found. The ForePass device could provide unmatched treatment for millions of people who reject invasive surgery or do not respond to drugs, the researchers said. The study led by Manoel Galvao Neto, from Sri Aurobindo Medical College in Madhya Pradesh, found that the ForePass endoscopic showed extraordinary efficacy in treating conditions such as severe obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH). Results, published in the journal Gut, revealed a 79 per cent reduction in weight gain compared to the control group, suggesting it may be substantially more effective than common metabolic surgeries like gastric bypass. The study also showed substantial improvements in how the body handles insulin and reduces glucose

Incisionless device could revolutionise treatment for metabolic diseases
Updated On : 21 Jan 2024 | 3:58 PM IST

Eli Lilly's Mounjaro gives positive results in obese diabetic people

Diabetes occurs when the body loses the ability to control blood sugar, and it's one of the world's most common serious diseases

Eli Lilly's Mounjaro gives positive results in obese diabetic people
Updated On : 24 Jun 2023 | 8:04 AM IST

Covid vax, booster dose immunity to decline rapidly in obese people: Study

A modest increase in risk was also seen in people with obesity (30-39.9kg/m2), and those who were underweight

Covid vax, booster dose immunity to decline rapidly in obese people: Study
Updated On : 12 May 2023 | 1:21 PM IST

British court rejects Kellogg's arguments against new sugar rules

Breakfast food giant Kellogg Co. lost a legal bid on Monday to block new anti-obesity measures in England banning the promotion of sugary cereals. The US company that makes Coco Pops, Frosted Flakes, Frosties and Rice Krispies had challenged the UK government over regulations taking effect in October restricting the promotion of foods high in fat, sugar or salt. A High Court judge rejected the company's argument that the regulations don't take into account the nutritional value of milk added to cereal. Judge Thomas Linden said that mixing a breakfast cereal that's high in sugar with milk does not change the fact that it's high in sugar. Kellogg's argument that its cereals like Crunchy Nut Clusters and Milk Chocolate Curls somehow become healthy products if they are consumed with milk is wholly unconvincing, as the addition of milk does not alter the nutritional profile of the products themselves," the judge wrote. Under the regulations, unhealthy foods will be banned from high-pro

British court rejects Kellogg's arguments against new sugar rules
Updated On : 04 Jul 2022 | 10:14 PM IST

Nearly one-fourth of all men and women in India are now obese: NFHS

NFHS notes steady increase in obesity among women as household wealth increases

Nearly one-fourth of all men and women in India are now obese: NFHS
Updated On : 06 May 2022 | 10:33 PM IST
How keeping a check on weight can help you avoid knee-related issues
Updated On : 25 Jan 2020 | 11:04 PM IST

Avoid obesity, maintain healthy lifestyle to lower risk of knee replacement

A balanced diet can help in maintaining good metabolism in the body in patients with obesity, diabetes, and cardiac illness

Avoid obesity, maintain healthy lifestyle to lower risk of knee replacement
Updated On : 07 Dec 2019 | 10:54 PM IST

'Fat but fit'? The controversy continues

A new study says that obese people are still more likely to develop heart disease than their peers who aren't overweight

'Fat but fit'? The controversy continues
Updated On : 28 Oct 2017 | 10:33 PM IST